AI adoption is accelerating across the healthcare sector, bringing both opportunities and real risk. Regulatory bodies globally are grappling with how to regulate AI in healthcare while the technology evolves rapidly, creating sustained demand for regulatory guidance.
The biggest risk, however, is doing nothing.
Join us for a panel discussion with Phil O'Sullivan, Partner at Allens, Romain Bonjean, CEO at RoseRx, Yass Omar, Compliance and Regulatory Affairs Specialist at Heidi Health and Rochana Wickramasinghe, Vice President at Pi Health on the steps that enable innovative and responsible use of AI across the healthcare industry.
This event brings together experts in the field to look at some of the key issues we are all facing.
In the session, we'll cover:
-
first-time AI use by organisations;
-
key challenges procuring AI;
-
AI governance frameworks;
-
data and privacy considerations; and
-
regulatory interactions.
Limited places available
👉 Secure your seat by February 11, 2026
